Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
Guoqiao Wang, Yan Li, Chengjie Xiong, et al.
Nature Medicine
|
October 16, 2023
Author Correction: Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)
Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Nature Medicine
|
April 24, 2023
Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, et al.
Frontiers in Aging Neuroscience
|
July 5, 2022
Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials
Andrew J Aschenbrenner, Jason Hassenstab, Guoqiao Wang, et al.
Brain : a Journal of Neurology
|
March 24, 2017
Clinical and genetic characterization of leukoencephalopathies in adults
David S Lynch, Anderson Rodrigues Brandão de Paiva, Wei Jia Zhang, et al.
JAMA Network Open
|
September 24, 2021
Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial
Peter A Ljubenkov, Lauren Edwards, Leonardo Iaccarino, et al.
Eclinicalmedicine
|
August 17, 2021
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study
Laura A Benjamin, Ross W Paterson, Rachel Moll, et al.
Brain Communications
|
January 17, 2024
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
Maxime Taquet, Zuzanna Skorniewska, Henrik Zetterberg, et al.
The Lancet. Neurology
|
July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
Anne M Fagan, Rachel L Henson, Yan Li, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
Guoqiao Wang, Yan Li, Chengjie Xiong, et al.
Nature Medicine
|
October 16, 2023
Author Correction: Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)
Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Nature Medicine
|
April 24, 2023
Tau-targeting antisense oligonucleotide MAPT<sub>Rx</sub> in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, et al.
Frontiers in Aging Neuroscience
|
July 5, 2022
Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials
Andrew J Aschenbrenner, Jason Hassenstab, Guoqiao Wang, et al.
Brain : a Journal of Neurology
|
March 24, 2017
Clinical and genetic characterization of leukoencephalopathies in adults
David S Lynch, Anderson Rodrigues Brandão de Paiva, Wei Jia Zhang, et al.
JAMA Network Open
|
September 24, 2021
Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial
Peter A Ljubenkov, Lauren Edwards, Leonardo Iaccarino, et al.
Eclinicalmedicine
|
August 17, 2021
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study
Laura A Benjamin, Ross W Paterson, Rachel Moll, et al.
Brain Communications
|
January 17, 2024
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
Maxime Taquet, Zuzanna Skorniewska, Henrik Zetterberg, et al.
The Lancet. Neurology
|
July 24, 2021
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
Anne M Fagan, Rachel L Henson, Yan Li, et al.
Page
of 8